Bibliografía del artículo
1. Davis AC. The prevalence of hearing impairment and reported hearing disability among adults in Great Britain. Int J Epidemiol 18:911-7, 1989.
2. Joint Committee on Infant Hearing Year 2000 Position Statement. Principles and guidelines for early hearing detection and intervention programs. www.audiology.org/professional/positions/jcih-early.php, 2006.
3. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci 630:16-31, 1991.
4. Mustafa T, Arnos KS, Pandya A. Advances in hereditary deafness. Lancet 358:1082-1090, 2001.
5. Skvorak Giersch AB, Morton CC. Genetic causes of nonsyndromic hearing loss. Curr Opin Pediatr 11(6):551-557, 1999.
6. Petty RKH, Harding AE, Morgan-Hughes JA. The clinical features of mitochondrial myopathy. Brain 109:915-38, 1986.
7. Nass MM. The circularity of mitochondrial DNA. Proc Natl Acad Sci USA 56:1215-22, 1966.
8. Sinclair JH, Stevens BJ. Circular DNA filaments from mouse mitochondria. Proc Natl Acad Sci USA 56: 208-14, 1966.
9. Van Bruggen EF, Borst P, Ruttenberg GJ, Gruber M, Kroon AM. Circular mitochondrial DNA. Biochim Biophys Acta 119-437-9, 1966.
10. Anderson S, Bankier AT, Barrel BG, Bruijn MHL, Coulson AR, Drouin J, et al. Sequence and organization of the human mitochondrial genome. Nature 290:457-65, 1981.
11. Maillet M. Biologia Celular. São Paulo:Santos, 279-302, 2003.
12. Wallace DC. Diseases of the mitochondrial DNA. Annu Rev Biochem 1175-212, 1992.
13. Hutchin TP, Thompson KR, Newton V, Bitner-Glindzicz M, Mueller RF. Prevalence of mitochondrial DNA mutations in childhood/congenital onset non-syndromal sensorineural hearing impairment. J Med Genet 38:229-31, 2001.
14. Prezant TR, Agapian JV, Bohlman MC, et al. Mitochondrial ribosomal RNA mutation associated with both antibiotic-induced and non-syndromic deafness. Nat Genet 4:289-294, 1993.
15. Seidman MD, Khan MJ, Bai UP, et al. The association of mitochondrial DNA deletions and cochlear pathology: a molecular biologic tool. Laryngoscope 106:777-83, 1996.
16. Guan MX, Fischel-Ghodsian N, Attardi G. A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity. Hum Mol Genet 9:1787-1793, 2000.
17. Giordano C, Pallotti F, Walker WF, et al. Pathogenesis of the deafness-associated A1555G mitochondrial DNA mutation. Biochem Biophys Res Commun 293:521-529, 2002.
18. Tamagawa Y, Kitamura K, Ishida T, et al. Mitochondrial DNA mutation at nucleotide 1555 in a patient with bilateral sensorineural hearing loss of unknown etiology. Acta Otolaryngol 116:796-796, 1996.
19. Estivill X, Govea N, Barceló A, et al. Familial progressive sensorineural deafness is mainly due to the mtDNA A1555G mutation and is enhanced by treatment with aminoglycosides. Am J Hum Genet 62:27-35, 1998.
20. Scrimshaw BJ, Faed JM, Tate WP, Yun K. Rapid identification of an A1555G mutation in human mitochondrial DNA implicated in aminoglycoside-induced ototoxicity. J Hum Genet 44:388-390, 1999.
21. Usami S, Abe S, Akita J, et al. Prevalence of mitochondrial gene mutations among hearing impaired patients. J Med Genet 37:38-40, 2000.
22. Oshima T, Kudo T, Ikeda K. Point mutation of the mitochondrial genome in Japanese deaf-mutism. ORL J Otorhinolaryngol Relat Spec 63:329-332, 2001.
23. Kupka S, Toth T, Wrobel M, Zeissler U, et al. Mutation A1555G in the 12S rRNA gene and its epidemiological importance in German, Hungarian, and Polish patients. Hum Mutat 19:308-309, 2002.
24. Østergaard E, Montserrat-Sentis B, GrønsKov K, Brøndum-Nielsen K. The A1555G mtDNA mutation in Danish hearing-impaired patients: frequency and clinical signs. Clin Genet 62:303-305, 2002.
25. Malik SG, Pieter N, Sudoyo H, Kadir A, Marzuki S. Prevalence of the mitochondrial DNA A1555G mutation in sensorineural deafness in Island Southeast Asia. J Hum Genet 48:180-483, 2003.
26. Tekin M, Duman T, Bogoçlu G, et al. Frequency of mtDNA A1555G and A7445G mutations among children with prelingual deafness in Turkey. Eur J Pediatr 162:154-158, 2003.
27. Iwasaki S, Tamagawa Y, Ocho S, et al. Hereditary sensorineural hearing loss of unknown cause involving mitochondrial DNA 1555 mutation. ORL J Otorhinolaryngol Relat Spec 62:100-103, 2002.
28. Matsunaga T, Kumanomido H, Shiroma M, et al. Deafness due to A1555G mitochondrial mutation without use of aminoglycoside. Laryngoscope 114:1085-1090, 2004.
29. Abreu-Silva RS, LezIrovitz K, Braga MCC, et al. Prevalence of the A1555G (12S rRNA) and tRNASer (UCN) mitochondrial mutations in hearing-impaired Brazilians patients. Braz J Med Biol Res 39:219-226, 2006.
30. Lindane AW, Marzuki S, Ozawa T, et al. Mitochondrial DNA mutations as an important contributor to aging and degenerative diseases. Lancet 1:642-5, 1985.
31. Yen TC, Su JH, King KL. Ageing-associated 5kb deletion in human liver mitochondrial DNA. Biochem Byophys Res Commun 178:124-31, 1991.
32. Cortopassi GA, Arnheim N. Detection of a specific mitochondrial DNA deletion in tissues of older humans. Nucleic Acid Res 18:6927-33, 1990.
33. Seidman MD, Ahmad N, Bai U. Molecular mechanisms of age-related hearing loss. Ageing Res Rev 331-43, 2002.
34. Bai U, Seidman MD, Hinojosa R, Quirk WS. Mitochondrial DNA deletions associated with aging and possibly presbicusis: a human archival temporal bone study. Am J Otol 18:449-53, 1997.
35. Fischel-Ghodsian N, Bykhovskaya Y, Taylor K, Kahen T, Cantor R, Ehrenman K, Smith R, Keithley E. Temporal bone analysis of patients with presbycusis reveals high frequency of mitochondrial mutations. Hear Res 110:147-54, 1997.
36. Ueda N, Oshima T, Ikeda K, Abe K, Aoki M, Takasaka T. Mitochondrial DNA deletions a predisposing cause for sensorineural hearing loss. Laryngoscope 108:580-4, 1998.
37. Han W, Han D, Jiang S. Mitochondrial DNA4977 deletions associated with human presbycusis. Zhonghua Er Bi Yan Za Zhi 35:416-9, 2000.
38. Keithley E, Harris B, Desai K, Linthicum F, Fischel-Ghodsian N. Mitochondrial cytochrome oxidase immunolabeling in aged human temporal bones. Hear Res 157:93-9, 2001.
39. Fischel-Ghodsian N. Mitochondrial deafness. Ear Hear 24:303-13, 2003.
40. Dai P, Yang W, Jiang S, Gu R, Yuan H, Han D, Guo W, Cao J. Correlation of cochlear blood supply with mitochondrial DNA common deletion in presbiacusis. Acta Otolaryngol 124:130-6, 2004.
41. Pickles JO. Mutation in mitochondrial DNA as a cause of presbyacusis. Audiol Neurootol 9:23-33, 2004.
42. Seidman MD, Ahmad N, Joshi D, Seidman J, Thawani S, Quirk WS. Age-related hearing loss and its association with reactive oxygen species and mitochondrial DNA damage. Acta Otolaryngol 552:16-24, 2004.
43. Noguchi Y, Yashima T, Ito T et al. Audiovestibular findings in patients with mitochondrial A1555G mutation. Laryngoscope 114:344-8, 2004.
44. Andrews RM, Kubacha I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147, 1999.
45.Oshima T, Ueda N, Ikeda K, Abe K, Takasaka T. Bilateral sensorineural hearing loss associated with the point mutation in the mitochondrial genome. Laryngoscope 106:43-8, 1996.
46. Keithley EM, Ryan AF, Feldman ML. Cochlear degeneration in aged rats of four strains. Hear Res 59, 171-178, 1992.
47. Zhang C, Baumer A, Maxwell RJ, Linnane AW, Nagley P. Multiple mitochondrial DNA deletions in an elderley human individual. FEBS Lett 297:34-8, 1992.
48. Belintani Piatto V, Maria Goloni Bertollo E, Lúcia Sartorato E, Victor Maniglia J. Prevalence of the GJB2 mutations and the del(GJB6-D13S1830) mutation in Brazilian patients with deafness. Hear Res 196:87-93, 2004.
49. Tekin M, Akar N, Cin S, et al. Connexin 26 (GJB2) mutations in the Turkish population: implications for the origin and high frequency of the 35 delG mutation in Caucasians. Human Genet 108:385-9, 2001.
50. Abe S, Usami S, Shinkawa H, Kelley PM, Kimberling WJ. Prevalent connexin 26 gene (GJB2) mutations in Japanese. J Med Genet 37:41-3, 2000.
51. Pandya A, Tekin M, Erdenetungalag R, et al. A unique spectrum of alterations in the Cx26 gene in deaf probands from Mongolia. Eur J Hum Genet 9:388, 2001.
52. Matsunaga T Kumanomido H, Shiroma M, Goto Y, Usami S. Audiological features and mitochondrial DNA sequence in a large family carrying mitochondrial A1555G mutation without use of aminoglycoside. Ann Otol Rhinol Laryngol 114:153-60, 2005.
53. Pandya A, Xia X, Radnaabazar J, Batsuuri J, Dangaansuren B, Fischel-Ghodsian N, Nance WE. Mutation in the mitochondrial 12S rRNA gene in two families from Mongolia with matrilineal aminoglycoside ototoxicity. J Med Genet 34:169-72, 1997.
54. Gardner JC, Goliath R, Viljoen D, et al. Familial streptomycin ototoxicity in a South African family: a mitochondrial disorder. J Med Genet 34:904-6, 1997.
55. Hutchin T, Cortopassi G. Mitochondrial DNA haplotype predicts deafness risk. Am J Med Genet 60:592, 1995.
56. Usami S, Abe S, Kasai M, et al. Genetic and clinical features of sensorineural hearing loss associated with the 1555 mitochondrial mutation. Laryngoscope 107:438-90, 1997.
57. Kleomitis E, Iliadis T, Voyiatzis N, et al. Analysis of the A1555G mtDNA mutation in Greek patients with sensorineural deafness. Am J Hum Genet 67:1879, 2000.
58. Tang HY, Hutcheson E, Neil S Drummond-Borg M, Sper M, Alford RL. Genetic susceptibility to aminoglycoside ototoxicity: How many are at risk? Genet Med 4:336-45, 2002.
59. Dent KM, Kenneson A, Palumbos JC, et al. Methodology of a multistate study of congenital hearing loss: preliminary data from Utah newborn screening. Am J Med Genet C Semin Med Genet 125:28-34, 2004.
60. Gravina LP, Foncuberta ME, Estrada RC, Barreiro C, Chertkoff L. Carrier frequency of the 35delG and A1555G deafness mutations in the Argentinean population impact on the newborn hearing screening. Int J Pediatr Otorhinolaryngol 4:639-43, 2007.